Cetraxal Comp 3 mg/ ml / 0.25 mg/ ml Noruega - norueguês - Statens legemiddelverk

cetraxal comp 3 mg/ ml / 0.25 mg/ ml

poa pharma scandinavia ab - ciprofloksacinhydroklorid / fluocinolonacetonid - Øredråper, oppløsning i endosebeholder - 3 mg/ ml / 0.25 mg/ ml

Ducressa 1 mg/ ml / 5 mg/ ml Noruega - norueguês - Statens legemiddelverk

ducressa 1 mg/ ml / 5 mg/ ml

santen oy (1) - deksametasonnatriumfosfat / levofloksacinhemihydrat - Øyedråper, oppløsning - 1 mg/ ml / 5 mg/ ml

Okedi União Europeia - norueguês - EMA (European Medicines Agency)

okedi

laboratorios farmacéuticos rovi, s.a. - risperidone - schizofreni - psykoleptiske - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Competact União Europeia - norueguês - EMA (European Medicines Agency)

competact

cheplapharm arzneimittel gmbh - pioglitazone, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

Lyxumia União Europeia - norueguês - EMA (European Medicines Agency)

lyxumia

sanofi winthrop industrie - lixisenatide - diabetes mellitus, type 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Gallium (Ga67) Citrate 37 MBq/ ml Noruega - norueguês - Statens legemiddelverk

gallium (ga67) citrate 37 mbq/ ml

mallinckrodt medical b.v. - gallium (67ga) sitrat - injeksjonsvæske, oppløsning - 37 mbq/ ml

Nanocis 0.15 mg Noruega - norueguês - Statens legemiddelverk

nanocis 0.15 mg

cis bio international - rheniumsulfid - injeksjonsvæske, oppløsning - 0.15 mg

MERON PLUS AC Itália - norueguês - Ministero della Salute

meron plus ac

Quinsair União Europeia - norueguês - EMA (European Medicines Agency)

quinsair

chiesi farmaceutici s.p.a - levofloxacin - cystic fibrosis; respiratory tract infections - antibakterielle midler for systemisk bruk, - quinsair er indisert for behandling av kronisk lunge infeksjoner forårsaket av pseudomonas aeruginosa hos voksne pasienter med cystisk fibrose. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Depo-Medrol 40 mg/ ml Noruega - norueguês - Statens legemiddelverk

depo-medrol 40 mg/ ml

pfizer as - metylprednisolonacetat - injeksjonsvæske, suspensjon - 40 mg/ ml